Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurosecretory Systems | 1 | 2019 | 230 | 0.630 |
Why?
|
Patient Care | 1 | 2021 | 626 | 0.520 |
Why?
|
Glioma | 2 | 2020 | 3318 | 0.520 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1107 | 0.510 |
Why?
|
Neuropeptides | 1 | 2020 | 929 | 0.500 |
Why?
|
Neuroendocrine Tumors | 1 | 2020 | 577 | 0.500 |
Why?
|
Lassa Fever | 4 | 2018 | 95 | 0.490 |
Why?
|
Rectal Neoplasms | 1 | 2021 | 1141 | 0.430 |
Why?
|
Radiation Injuries | 1 | 2019 | 1167 | 0.410 |
Why?
|
Lassa virus | 3 | 2015 | 94 | 0.350 |
Why?
|
Brain Neoplasms | 2 | 2020 | 8657 | 0.330 |
Why?
|
Prostatic Neoplasms | 2 | 2021 | 10884 | 0.310 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3711 | 0.310 |
Why?
|
Orthopedics | 2 | 2011 | 877 | 0.260 |
Why?
|
Musculoskeletal Diseases | 1 | 2011 | 561 | 0.260 |
Why?
|
Educational Measurement | 1 | 2011 | 1261 | 0.230 |
Why?
|
Teaching | 1 | 2011 | 1164 | 0.230 |
Why?
|
Adenocarcinoma | 1 | 2020 | 6355 | 0.220 |
Why?
|
Education, Medical, Undergraduate | 1 | 2011 | 999 | 0.210 |
Why?
|
Pandemics | 1 | 2021 | 7851 | 0.200 |
Why?
|
Semen | 1 | 2023 | 302 | 0.190 |
Why?
|
Craniopharyngioma | 1 | 2023 | 279 | 0.190 |
Why?
|
Curriculum | 1 | 2011 | 3524 | 0.150 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 248 | 0.150 |
Why?
|
Standard of Care | 1 | 2021 | 531 | 0.150 |
Why?
|
Comparative Effectiveness Research | 1 | 2021 | 688 | 0.130 |
Why?
|
Pituitary Neoplasms | 1 | 2023 | 1317 | 0.130 |
Why?
|
Confidence Intervals | 1 | 2020 | 2977 | 0.120 |
Why?
|
Statistics, Nonparametric | 1 | 2020 | 2897 | 0.120 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20448 | 0.120 |
Why?
|
Infection Control | 1 | 2021 | 951 | 0.120 |
Why?
|
Prostate | 1 | 2020 | 1679 | 0.110 |
Why?
|
Patient Admission | 1 | 2019 | 1371 | 0.100 |
Why?
|
Genome, Viral | 1 | 2015 | 688 | 0.100 |
Why?
|
Visual Cortex | 1 | 2019 | 1156 | 0.100 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2012 | 176 | 0.100 |
Why?
|
Selection, Genetic | 2 | 2013 | 902 | 0.100 |
Why?
|
Genetic Techniques | 1 | 2013 | 442 | 0.090 |
Why?
|
Linear Models | 1 | 2020 | 5937 | 0.090 |
Why?
|
Genome, Human | 2 | 2013 | 4430 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2743 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2150 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9700 | 0.080 |
Why?
|
Bone Plates | 1 | 2011 | 452 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 9588 | 0.080 |
Why?
|
Interleukins | 1 | 2012 | 790 | 0.080 |
Why?
|
Radiology | 1 | 2021 | 2019 | 0.070 |
Why?
|
RNA, Viral | 1 | 2015 | 2894 | 0.070 |
Why?
|
Cholera | 1 | 2013 | 776 | 0.070 |
Why?
|
Disease Progression | 2 | 2023 | 13157 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12329 | 0.070 |
Why?
|
Radius Fractures | 1 | 2011 | 477 | 0.070 |
Why?
|
Fracture Fixation, Internal | 1 | 2011 | 858 | 0.060 |
Why?
|
Clinical Competence | 2 | 2011 | 4671 | 0.060 |
Why?
|
Prosthesis Design | 1 | 2011 | 2089 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3059 | 0.060 |
Why?
|
Humans | 18 | 2023 | 725187 | 0.060 |
Why?
|
Nigeria | 2 | 2018 | 704 | 0.060 |
Why?
|
Africa, Western | 2 | 2015 | 147 | 0.060 |
Why?
|
Schools, Medical | 1 | 2011 | 873 | 0.060 |
Why?
|
Risk Assessment | 3 | 2021 | 23185 | 0.060 |
Why?
|
Algorithms | 2 | 2021 | 13765 | 0.060 |
Why?
|
Evolution, Molecular | 1 | 2012 | 1941 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9379 | 0.060 |
Why?
|
Male | 9 | 2023 | 347096 | 0.060 |
Why?
|
Fellowships and Scholarships | 1 | 2010 | 1022 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5059 | 0.050 |
Why?
|
Leadership | 1 | 2010 | 1331 | 0.050 |
Why?
|
Adult | 7 | 2023 | 211615 | 0.050 |
Why?
|
Prospective Studies | 2 | 2019 | 51869 | 0.050 |
Why?
|
Cryotherapy | 1 | 2021 | 152 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 649 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13576 | 0.050 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2021 | 616 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2023 | 3643 | 0.040 |
Why?
|
Quality of Life | 1 | 2019 | 12111 | 0.040 |
Why?
|
Students, Medical | 1 | 2011 | 1827 | 0.040 |
Why?
|
Remission Induction | 1 | 2023 | 2368 | 0.040 |
Why?
|
Mutation | 3 | 2023 | 29672 | 0.040 |
Why?
|
Female | 7 | 2021 | 375449 | 0.040 |
Why?
|
Heart Failure | 1 | 2019 | 10381 | 0.030 |
Why?
|
Murinae | 1 | 2015 | 19 | 0.030 |
Why?
|
Disease Reservoirs | 1 | 2015 | 135 | 0.030 |
Why?
|
Zoonoses | 1 | 2015 | 179 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 20941 | 0.030 |
Why?
|
NF-kappa B | 2 | 2013 | 2549 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2013 | 11968 | 0.030 |
Why?
|
Sierra Leone | 1 | 2014 | 155 | 0.030 |
Why?
|
Organoids | 1 | 2019 | 689 | 0.030 |
Why?
|
Rivers | 1 | 2013 | 64 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2004 | 0.030 |
Why?
|
Toll-Like Receptor 5 | 1 | 2013 | 39 | 0.030 |
Why?
|
Ebolavirus | 1 | 2015 | 252 | 0.030 |
Why?
|
Brain | 1 | 2019 | 25764 | 0.030 |
Why?
|
Flagellin | 1 | 2013 | 126 | 0.030 |
Why?
|
Phylogeography | 1 | 2012 | 84 | 0.030 |
Why?
|
Ribavirin | 1 | 2014 | 397 | 0.030 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2013 | 187 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2023 | 4875 | 0.030 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2015 | 404 | 0.020 |
Why?
|
Immunoassay | 1 | 2014 | 751 | 0.020 |
Why?
|
Middle Aged | 3 | 2019 | 212292 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2014 | 1143 | 0.020 |
Why?
|
Biological Evolution | 1 | 2015 | 1073 | 0.020 |
Why?
|
Wrist Injuries | 1 | 2011 | 200 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7241 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2011 | 15019 | 0.020 |
Why?
|
Models, Genetic | 1 | 2019 | 3502 | 0.020 |
Why?
|
Inflammasomes | 1 | 2013 | 464 | 0.020 |
Why?
|
Fracture Healing | 1 | 2011 | 410 | 0.020 |
Why?
|
Inpatients | 1 | 2019 | 2395 | 0.020 |
Why?
|
Seasons | 1 | 2014 | 1470 | 0.020 |
Why?
|
Injury Severity Score | 1 | 2011 | 991 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1736 | 0.020 |
Why?
|
Viral Proteins | 1 | 2015 | 1952 | 0.020 |
Why?
|
Glycoproteins | 1 | 2015 | 2297 | 0.020 |
Why?
|
Vibrio cholerae | 1 | 2013 | 809 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9288 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4257 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2019 | 61761 | 0.020 |
Why?
|
Sex Distribution | 1 | 2011 | 2315 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6163 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3048 | 0.020 |
Why?
|
Age Distribution | 1 | 2011 | 2918 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2013 | 1994 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 2011 | 1546 | 0.020 |
Why?
|
Incidence | 2 | 2014 | 20750 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2019 | 74206 | 0.020 |
Why?
|
Program Development | 1 | 2010 | 1318 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12249 | 0.020 |
Why?
|
Joint Instability | 1 | 2011 | 767 | 0.020 |
Why?
|
Reference Values | 1 | 2010 | 4999 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13358 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2014 | 3083 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 39918 | 0.010 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2014 | 2010 | 0.010 |
Why?
|
Bacteria | 1 | 2013 | 2117 | 0.010 |
Why?
|
Program Evaluation | 1 | 2010 | 2486 | 0.010 |
Why?
|
Pain Measurement | 1 | 2011 | 3411 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 19624 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10251 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 57656 | 0.010 |
Why?
|
Radiography | 1 | 2011 | 6935 | 0.010 |
Why?
|
Genetic Variation | 1 | 2015 | 6539 | 0.010 |
Why?
|
Animals | 3 | 2019 | 168714 | 0.010 |
Why?
|
Societies, Medical | 1 | 2010 | 3706 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2010 | 2251 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40186 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18339 | 0.010 |
Why?
|
Young Adult | 2 | 2014 | 55781 | 0.010 |
Why?
|
Aged | 2 | 2019 | 161486 | 0.010 |
Why?
|
Risk Factors | 1 | 2019 | 71009 | 0.010 |
Why?
|
Pregnancy | 1 | 2014 | 28145 | 0.010 |
Why?
|
Mice | 1 | 2019 | 80300 | 0.010 |
Why?
|
Infant | 1 | 2014 | 34337 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 17354 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 40440 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2010 | 24031 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2011 | 38748 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23448 | 0.010 |
Why?
|
Child | 1 | 2014 | 75163 | 0.000 |
Why?
|
Adolescent | 1 | 2014 | 84401 | 0.000 |
Why?
|
United States | 1 | 2010 | 68403 | 0.000 |
Why?
|
Concepts
(163)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(99)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_